A West Coast biotech entrepreneur says he’s secured $30 million to form a public-benefit company to study how to safely create genetically edited babies, marking the largest known investment into the ...
In a world first, a bespoke gene-editing therapy benefitted one child. Now reseachers plan to launch a clinical trial of the ...
The U.S. government is divesting from mRNA vaccines, but will other uses of the technology be spared? In a time of ...
The Boston biotech founded by Harvard professor David Sinclair is testing whether cellular reprogramming can turn back the ...
Seven years after the first gene-edited babies were revealed, biotech startup Manhattan Genomics is reviving the idea of ...
Swiss Rockets, MGI US LLC and Complete Genomics Inc. announced today that they entered into a exclusive license agreement ...
TipRanks on MSN
Tenaya Therapeutics Advances Gene Therapy Study for ARVC
Tenaya Therapeutics, Inc. (($TNYA)) announced an update on their ongoing clinical study. Tenaya Therapeutics, Inc. is conducting a pivotal ...
This article examines key innovations driving scalable, high-yield purification of recombinant AAVs and how they’re helping ...
French dairy giant Bel Group and precision fermentation firm Standing Ovation have produced casein with dairy industry waste ...
For more than 40 years, the person responsible for the brutal rape and murder of a 16-year-old girl on Long Island has eluded capture. DNA from a smoothie straw, prosecutors say, could now be the key ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback